Amarin Corporation plc (AMRN)

Check out top investors' recommendation for AMRN
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
10.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Louise Chen Guggenheim Securities LLC Buy   Dec 06, '17     10.00  Dec 06, '18  N/A 
Andrew Fein Chardan Capital Markets Buy   Nov 02, '17     10.00  Nov 02, '18  N/A 
Louise Chen Guggenheim Securities LLC Buy   Nov 01, '17     10.00  Nov 01, '18  N/A 
Louise Chen Guggenheim Securities LLC Buy   Sep 26, '17     10.00  Sep 26, '18  N/A 
Louise Chen Guggenheim Securities LLC Buy   Aug 14, '17     10.00  Aug 14, '18  N/A 
Andrew Fein Chardan Capital Markets Buy   Aug 03, '17     10.00  Aug 03, '18  N/A 
Andrew Fein Chardan Capital Markets Buy   Jun 27, '17     10.00  Jun 27, '18  N/A 
Louise Chen Guggenheim Securities LLC Buy   Jun 26, '17     10.00  Jun 26, '18  N/A 
Andrew Fein Chardan Capital Markets Buy   Jan 23, '17     10.00  Jan 23, '18  N/A 
Thomas Wei Jefferies & Co. Buy   Nov 04, '16     4.50  Nov 04, '17  N/A 
Jonathan Eckard Citi Buy   Oct 19, '16     5.00  Oct 19, '17  N/A 
Andrew Fein Chardan Capital Markets Buy   Feb 26, '16   1.45  10.00  Feb 26, '17  128.97% 
JESUS NAVARRETE Unaffiliated Buy   Apr 07, '15   2.42  6.47  Apr 07, '16  -33.47% 
Andrew Fein Chardan Capital Markets Buy   Mar 12, '15   2.38    Mar 12, '16  -31.93% 
Thomas Wei Jefferies & Co. Buy   Apr 01, '14   1.92    Apr 01, '15  21.88% 
Jon Lecroy MKM Partners LLC Buy   Nov 08, '13   1.57  2.50  Nov 08, '14  -42.68% 
Ram Selvaraju Aegis Capital Buy   Oct 14, '13   5.01    Oct 14, '14  -80.24% 
Joseph Schwartz Leerink Swann Llc Buy   Oct 14, '13   5.01    Oct 14, '14  -80.24% 
Thomas Wei Jefferies & Co. Buy   Oct 10, '13   6.37    Oct 10, '14  -84.62% 
Ram Selvaraju Aegis Capital Buy   Sep 13, '13   6.60    Sep 13, '14  -77.42% 
< previous12